Niklas Finnberg

Citado por

	Total	Desde 2020
Citas	2021	795
Índice h	21	13
Índice i10	28	19

200

100

150

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202512 16 25 34 46 45 50 69 69 80 80 93 157 138 145 151 183 185 174 108 127 18

Acceso público

Ver todo

15 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Wafik El-DeiryAssociate Dean, Warren Alpert Medical School, Brown UniversityDirección de correo verificada de brown.edu
Prashanth GokareJanssen R&DDirección de correo verificada de yale.edu
Gregory J. GoresMayo ClinicDirección de correo verificada de mayo.edu
knight scImperial College London and Northwest London Hospitals TrustDirección de correo verificada de imperial.ac.uk
Ulla SteniusKarolinska InstitutetDirección de correo verificada de ki.se
Christian FingasDirección de correo verificada de uk-essen.de
Noboru MotoyamaSugiyama Jogakuen University, Department of Human NutritionDirección de correo verificada de sugiyama-u.ac.jp
Jeffrey FarmaFox Chase Cancer CenterDirección de correo verificada de fccc.edu
Junaid AbdulghaniAssistant Research ProfessorDirección de correo verificada de fccc.edu
Varun Vijay PrabhuSenior Director R&D, ChimerixDirección de correo verificada de chimerix.com
Joshua E AllenOncoceuticsDirección de correo verificada de oncoceutics.com
Nathan LeBrasseurMayo ClinicDirección de correo verificada de mayo.edu
Prof. Dr. Christian LiedtkeDepartment of Medicine III, Uniklinik RWTH Aachen, GermanyDirección de correo verificada de ukaachen.de
Krystle A. Lang KuhsAssociate Professor, University of KentuckyDirección de correo verificada de uky.edu
Sophie CazanaveAssistant ProfessorDirección de correo verificada de vcuhealth.org
Justin L. MottUniversity of Nebraska Medical CenterDirección de correo verificada de unmc.edu
Joshua GruberUT Southwestern Medical CenterDirección de correo verificada de utsouthwestern.edu
Gillies McKennaOxford Institute for Radiation OncologyDirección de correo verificada de oncology.ox.ac.uk
GS WuProfessor of Oncology, Wayne State UniversityDirección de correo verificada de wayne.edu
BORA LIMThe University of Texas MD Anderson Cancer CenterDirección de correo verificada de mdanderson.org

Seguir

Niklas Finnberg

ProPharma Group Sweden

Dirección de correo verificada de propharmagroup.com - Página principal

Non- and clinical cancer research immune-oncology biomarkers


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis T Condamine, V Kumar, IR Ramachandran, JI Youn, E Celis, N Finnberg, ... The Journal of clinical investigation 124 (6), 2626-2639, 2014	358	2014
TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis N Finnberg, AJP Klein-Szanto, WS El-Deiry The Journal of clinical investigation 118 (1), 2007	215	2007
Death receptor 5 signaling promotes hepatocyte lipoapoptosis SC Cazanave, JL Mott, SF Bronk, NW Werneburg, CD Fingas, XW Meng, ... Journal of Biological Chemistry 286 (45), 39336-39348, 2011	146	2011
DR5 knockout mice are compromised in radiation-induced apoptosis N Finnberg, JJ Gruber, P Fei, D Rudolph, A Bric, SH Kim, TF Burns, ... Molecular and cellular biology 25 (5), 2000-2013, 2005	143	2005
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures NK Finnberg, P Gokare, A Lev, SI Grivennikov, AW MacFarlane IV, ... Oncotarget 8 (40), 66747, 2017	135	2017
Targeting TRAIL in the treatment of cancer: new developments B Lim, JE Allen, VV Prabhu, MK Talekar, NK Finnberg, WS El-Deiry Expert opinion on therapeutic targets 19 (9), 1171-1185, 2015	115	2015
TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess L Idrissova, H Malhi, NW Werneburg, NK LeBrasseur, SF Bronk, C Fingas, ... Journal of hepatology 62 (5), 1156-1163, 2015	98	2015
The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo K Kuribayashi, NK Finnberg, JR Jeffers, GP Zambetti, WS El-Deiry Cell cycle 10 (14), 2380-2389, 2011	86	2011
Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo N Finnberg, C Wambi, JH Ware, AR Kennedy Cancer biology & therapy 7 (12), 2023-2033, 2008	76	2008
Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival CO Wambi, JK Sanzari, CM Sayers, M Nuth, Z Zhou, J Davis, N Finnberg, ... Radiation research 172 (2), 175-186, 2009	71	2009
Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype? N Finnberg, WS El-Deiry Cancer Biology & Therapy 3 (7), 614-616, 2004	65	2004
TRAIL death receptors as tumor suppressors and drug targets NK Finnberg, WS El-Deiry Cell Cycle 7 (11), 1525-1528, 2008	52	2008
Sorafenib and quinacrine target anti-apoptotic protein MCL1: a poor prognostic marker in anaplastic thyroid cancer (ATC) J Abdulghani, P Gokare, JN Gallant, D Dicker, T Whitcomb, T Cooper, ... Clinical Cancer Research 22 (24), 6192-6203, 2016	44	2016
Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions N Finnberg, I Silins, U Stenius, J Högberg Carcinogenesis 25 (1), 113-122, 2004	39	2004
Animal models of cancer biology NS Yee, N Ignatenko, N Finnberg, N Lee, D Stairs Cancer growth and metastasis 8, CGM. S37907, 2015	38	2015
Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients CL Kline, HS Sheikh, A Scicchitano, R Gingrich, C Beachler, NK Finnberg, ... Cancer biology & therapy 12 (7), 557-568, 2011	36	2011
Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation JE Meyer, NK Finnberg, L Chen, D Cvetkovic, B Wang, L Zhou, Y Dong, ... Cell Cycle 16 (12), 1171-1174, 2017	32	2017
P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting P Gokare, NK Finnberg, PH Abbosh, J Dai, ME Murphy, WS El-Deiry Scientific Reports 7 (1), 9711, 2017	31	2017
Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras A Navaraj, N Finnberg, DT Dicker, W Yang, EM Matthew, WS El-Deiry Cancer biology & therapy 8 (24), 2417-2444, 2009	24	2009
Heterozygous p53-deficient (+/−) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice N Finnberg, U Stenius, J Högberg Cancer letters 207 (2), 149-155, 2004	24	2004

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores